血浆置换法治疗30例重型肝炎的临床疗效观察  

Clinical Observation on 30 Patients with Severe Hepatitis in the Treatment of Plasma Exchange

作　　者：张雪梅[1] 杨应树 

机构地区：[1]四川省攀枝花市第四人民医院,攀枝花617061

出　　处：《透析与人工器官》2008年第1期28-29,共2页Chinese Journal of Dialysis and Artificial Organs

摘　　要：目的了解人工肝血浆置换治疗肝炎的存活率。方法30例重型肝炎患者在内科治疗基础上联合血浆置换治疗95例次,另随机抽取30例重型肝炎仅予内科治疗作对比。两者均予促干细胞生长素、还原型谷胱甘肽、人血白蛋白等内科综合治疗。结果30例重型肝炎患者经血浆置换治疗后,存活率为63.33%(19/30),而对照组仅为30%(9/30)。结论血浆置换对于重型肝炎是一种有效的治疗方法。Objective To know the survival rate of artificial liver plasma exchange in the treatment of hepatitis. Methods 30 patients with severe hepatitis were treated for 95 case-times combined with plasma exchange based on medical treatment and choose other 30 patients with severe hepatitis as a comparison with medical treatment. The two groups were both accepted promoting stem cells growth factor, glutathione and human albumin as medical comprehensive treatment. Results After the treatment by plasma exchange the survival rate of 30 patients with severe hepatitis is 63.33% （19/30）, while that of the control group is only 30% （9/30）. Conclusion Plasma exchange is an effective method for severe hepatitis.

关 键 词：血浆置换 治疗 重型肝炎 

分 类 号：R656[医药卫生—外科学]